Structure‐Guided In Silico Design of DprE1 Inhibitors Using Pharmacophore Modeling, Molecular Dynamics Simulations, ADME, and DFT Calculations
Compound 22 was computationally prioritized as a promising noncovalent DprE1‐binding candidate requiring further structural optimization and experimental validation and was computationally prioritized as a promising noncovalent DprE1‐binding candidate.